Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-FR Version v5-FR
Language French French
Date Updated 2020-02-28 2020-01-23
Drug Identification Number 02381389 02381389
Brand name EDARBI EDARBI
Common or Proper name EDARBI EDARBI
Company Name VALEANT CANADA LP/VALEANT CANADA S.E.C. VALEANT CANADA LP/VALEANT CANADA S.E.C.
Ingredients AZILSARTAN MEDOXOMIL AZILSARTAN MEDOXOMIL
Strength(s) 40MG 40MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 28ct 28ct
ATC code C09CA C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2020-01-06 2020-01-06
Estimated end date 2020-02-14
Actual end date 2020-02-18
Shortage status Resolved Actual shortage
Company comments awaiting documents QA delay in production
Health Canada comments